Intravenous Thrombolysis for Ischemic Stroke Patients with Pituitary Neoplasms: A Nationwide Study and Scoping Review.

NeuroSci · 2026 · PMC12922147 · PMID 41718148

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

a slight trendp = 0.054so close (0.05 < p ≤ 0.1)

Among IVT-treated patients, interaction analysis demonstrates that there were no significant differences in any of the examined outcomes between those with and without pituitary neoplasms (all interaction p > 0.05; Table 2 ), with a slight trend toward decreased ICH events in patients with pituitary neoplasms (OR 0.38 [95%CI: 0.15–1.02], p = 0.054). 4.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.